14th Feb 2007 14:37
Skyepharma PLC14 February 2007 For Immediate Release 14th FEBRUARY 2007 SKYEPHARMA TO PRESENT AT 19th ANNUAL ROTH CAPITAL PARTNERS GROWTH STOCK CONFERENCE LONDON, UK, 14 February 2007-- SkyePharma PLC (Nasdaq: SKYE; LSE: SKP) announcestoday that the Company's Chief Executive Officer, Frank Condella, will make apresentation at the 19th Annual Roth Capital Partners Growth Stock Conference in California, USA. Mr. Condella will deliver his presentation on Wednesday 21February 2007 at 9.30 p.m. (GMT). Investors may access a live webcast of thepresentation at www.skyepharma.com under the Investor Relations tab. Thepresentation will be archived for 3 months. For further information please contact: SkyePharma PLC +44 207 491 1777Frank Condella, Chief Executive OfficerKen Cunningham, Chief Operating OfficerPeter Grant, Finance Director Buchanan Communications +44 207 466 5000Tim Anderson / Mark Court / Rebecca Skye Dietrich The Trout Group + 1 617 583 1308Seth Lewis About SkyePharma PLC Using its proprietary drug delivery technologies, SkyePharma develops newformulations of known molecules to provide a clinical advantage and life-cycleextension. The Company has nine approved products in the areas of oral,inhalation and topical delivery that are marketed throughout the world byleading pharmaceutical companies. For more information, visitwww.skyepharma.com. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
SKP.L